Book Value per Share: amphastar.com (AMPH)

Amphastar Pharmaceuticals (AMPH) specializes in the production of complex generics and injectables, securing a stable revenue stream from hospitals. Current price action on GURU.Markets, where the indicator stands at 17.89, confirms the business's resilience. Management guarantees development transparency and high margins, while a loyal staff of regulatory experts and analytical chemists eliminates talent shortages in the R&D sector, sustaining the company's technological superiority.

Amphastar Pharmaceuticals Inc (AMPH): Share Book Value from 07/04/2022 to 10/27/2026

amphastar.com - analytical breakdowns and key metrics (AMPH)

- price and consensus price forecast:

Price Chart Amphastar|AMPH - Forecast Levels Chart

- market capitalization data:

Market Capitalization Amphastar Pharmaceuticals, Inc.|AMPH - Value Adjusted for Debt and Cash

- book capitalization data:

Net Assets per Single Share Amphastar Pharmaceuticals|AMPH - Net Asset Value|Market Capitalization to Book Value Ratio amphastar.com|AMPH - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Amphastar Pharmaceuticals|AMPH - Long-Term Debt to Capital|Short-Term Debt to Equity Amphastar Pharmaceuticals, Inc.|AMPH - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Amphastar Pharmaceuticals, Inc.

Fundamental company valuation:Amphastar - AMPH

Manufactured products of Amphastar Pharmaceuticals, Inc.

Book value separates the intrinsic resilience of assets from price volatility. This metric is calculated as the ratio of equity to the number of shares, determining the real value of an investor's stake. The BVPS trend allows for the tracking of net asset accumulation between reporting periods. For Amphastar Pharmaceuticals (AMPH), this margin of safety is bolstered by the ownership of complex drug delivery technologies. High barriers to entry in the inhalation drug niche ensure the preservation of the business value.

Competitors of Amphastar Pharmaceuticals (AMPH)